Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1977-1-3
pubmed:abstractText
Isoprenaline dose-response curves plotting increases in heart rate before and after labetalol are suggestive of competitive antagonism at beta-adrenoceptor sites. Phenylephrine dose-response curves using increases in systolic pressure before and after labetalol are suggestive of competitive antagonism at alpha-adrenoceptor sites. The ratio of alpha:beta-adrenoceptor antagonism induced by labetalol is approximately 1:3. Peak pharmacological responses after a single oral dose of labetalol (400 mg) occurred between 90-120 min after administration.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-13887414, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-13889121, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-14089056, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-186090, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-238705, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-242209, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4148916, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4362588, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4396864, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4404413, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4850484, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-4877600, http://linkedlifedata.com/resource/pubmed/commentcorrection/9968-802650
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
849-55
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1976
pubmed:articleTitle
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
pubmed:publicationType
Journal Article